The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Artis, D.
Right arrow Articles by Scott, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Artis, D.
Right arrow Articles by Scott, P.
The Journal of Immunology, 2004, 172: 4672-4675.
Copyright © 2004 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Early IL-4 Production Governs the Requirement for IL-27-WSX-1 Signaling in the Development of Protective Th1 Cytokine Responses following Leishmania major Infection1

David Artis*, Leanne M. Johnson*, Karen Joyce*, Christiaan Saris{dagger}, Alejandro Villarino*, Christopher A. Hunter* and Phillip Scott2,*

* Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104; and {dagger} Department of Inflammation Research, Amgen, Inc., Thousand Oaks, CA 91320

There are conflicting reports on the requirements for the IL-27-WSX-1 pathway in the development of Th type 1 responses and resistance to intracellular pathogens; although early IFN-{gamma} production and resistance to Leishmania major are impaired in the absence of WSX-1 signaling, WSX-1−/− mice generate robust IFN-{gamma} responses and control infection with other intracellular protozoan pathogens. In this report, we resolve these conflicting observations and demonstrate that, in the absence of IL-4, WSX-1 is not required for early IFN-{gamma} production and control of L. major. Thus, the requirement for WSX-1 signaling in Th type 1 cell differentiation is restricted to conditions in which IL-4 is produced.


Related articles in The JI:

IN THIS ISSUE

The JI 2004 172: 4659-4660. [Full Text]  



This article has been cited by other articles:


Home page
J. Immunol.Home page
C. F. Anderson, J. S. Stumhofer, C. A. Hunter, and D. Sacks
IL-27 Regulates IL-10 and IL-17 from CD4+ Cells in Nonhealing Leishmania major Infection
J. Immunol., October 1, 2009; 183(7): 4619 - 4627.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Kempe, P. Heinz, E. Kokai, O. Devergne, N. Marx, and T. Wirth
Epstein-Barr Virus-Induced Gene-3 Is Expressed in Human Atheroma Plaques
Am. J. Pathol., July 1, 2009; 175(1): 440 - 447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. G. Perrigoue, C. Zaph, K. Guild, Y. Du, and D. Artis
IL-31-IL-31R Interactions Limit the Magnitude of Th2 Cytokine-Dependent Immunity and Inflammation following Intestinal Helminth Infection
J. Immunol., May 15, 2009; 182(10): 6088 - 6094.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. V. Villarino, D. Artis, J. S. Bezbradica, O. Miller, C. J. M. Saris, S. Joyce, and C. A. Hunter
IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD
Int. Immunol., June 1, 2008; 20(6): 739 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Cao, P. D. Doodes, T. T. Glant, and A. Finnegan
IL-27 Induces a Th1 Immune Response and Susceptibility to Experimental Arthritis
J. Immunol., January 15, 2008; 180(2): 922 - 930.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Maroof and P. M. Kaye
Temporal Regulation of Interleukin-12p70 (IL-12p70) and IL-12-Related Cytokines in Splenic Dendritic Cell Subsets during Leishmania donovani Infection
Infect. Immun., January 1, 2008; 76(1): 239 - 249.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yoshimoto, T. Yoshimoto, K. Yasuda, J. Mizuguchi, and K. Nakanishi
IL-27 Suppresses Th2 Cell Development and Th2 Cytokines Production from Polarized Th2 Cells: A Novel Therapeutic Way for Th2-Mediated Allergic Inflammation
J. Immunol., October 1, 2007; 179(7): 4415 - 4423.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. M. Johnson and P. Scott
STAT1 Expression in Dendritic Cells, but Not T Cells, Is Required for Immunity to Leishmania major
J. Immunol., June 1, 2007; 178(11): 7259 - 7266.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Liu, X. Guan, and X. Ma
Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-{gamma}-mediated pathways
J. Exp. Med., January 22, 2007; 204(1): 141 - 152.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Owaki, M. Asakawa, F. Fukai, J. Mizuguchi, and T. Yoshimoto
IL-27 Induces Th1 Differentiation via p38 MAPK/T-bet- and Intercellular Adhesion Molecule-1/LFA-1/ERK1/2-Dependent Pathways
J. Immunol., December 1, 2006; 177(11): 7579 - 7587.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Larousserie, P. Charlot, E. Bardel, J. Froger, R. A. Kastelein, and O. Devergne
Differential Effects of IL-27 on Human B Cell Subsets
J. Immunol., May 15, 2006; 176(10): 5890 - 5897.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Owaki, M. Asakawa, S. Kamiya, K. Takeda, F. Fukai, J. Mizuguchi, and T. Yoshimoto
IL-27 Suppresses CD28-Medicated IL-2 Production through Suppressor of Cytokine Signaling 3.
J. Immunol., March 1, 2006; 176(5): 2773 - 2780.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. V. Villarino, J. S. Stumhofer, C. J. M. Saris, R. A. Kastelein, F. J. de Sauvage, and C. A. Hunter
IL-27 Limits IL-2 Production during Th1 Differentiation
J. Immunol., January 1, 2006; 176(1): 237 - 247.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. E. Rosas, A. A. Satoskar, K. M. Roth, T. L. Keiser, J. Barbi, C. Hunter, F. J. de Sauvage, and A. R. Satoskar
Interleukin-27R (WSX-1/T-Cell Cytokine Receptor) Gene-Deficient Mice Display Enhanced Resistance to Leishmania donovani Infection but Develop Severe Liver Immunopathology
Am. J. Pathol., January 1, 2006; 168(1): 158 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Shimizu, N. Sugiyama, K. Masutani, A. Sadanaga, Y. Miyazaki, Y. Inoue, M. Akahoshi, R. Katafuchi, H. Hirakata, M. Harada, et al.
Membranous Glomerulonephritis Development with Th2-Type Immune Deviations in MRL/lpr Mice Deficient for IL-27 Receptor (WSX-1)
J. Immunol., December 1, 2005; 175(11): 7185 - 7192.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Owaki, M. Asakawa, N. Morishima, K. Hata, F. Fukai, M. Matsui, J. Mizuguchi, and T. Yoshimoto
A Role for IL-27 in Early Regulation of Th1 Differentiation
J. Immunol., August 15, 2005; 175(4): 2191 - 2200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Miyazaki, H. Inoue, M. Matsumura, K. Matsumoto, T. Nakano, M. Tsuda, S. Hamano, A. Yoshimura, and H. Yoshida
Exacerbation of Experimental Allergic Asthma by Augmented Th2 Responses in WSX-1-Deficient Mice
J. Immunol., August 15, 2005; 175(4): 2401 - 2407.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Holscher, A. Holscher, D. Ruckerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and S. Ehlers
The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis
J. Immunol., March 15, 2005; 174(6): 3534 - 3544.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Pearl, S. A. Khader, A. Solache, L. Gilmartin, N. Ghilardi, F. deSauvage, and A. M. Cooper
IL-27 Signaling Compromises Control of Bacterial Growth in Mycobacteria-Infected Mice
J. Immunol., December 15, 2004; 173(12): 7490 - 7496.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Artis, A. Villarino, M. Silverman, W. He, E. M. Thornton, S. Mu, S. Summer, T. M. Covey, E. Huang, H. Yoshida, et al.
The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity
J. Immunol., November 1, 2004; 173(9): 5626 - 5634.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. V. Villarino, E. Huang, and C. A. Hunter
Understanding the Pro- and Anti-Inflammatory Properties of IL-27
J. Immunol., July 15, 2004; 173(2): 715 - 720.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.